Search

Your search keyword '"Fostira, Florentia"' showing total 776 results

Search Constraints

Start Over You searched for: Author "Fostira, Florentia" Remove constraint Author: "Fostira, Florentia"
776 results on '"Fostira, Florentia"'

Search Results

201. Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

202. Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer

203. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

204. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

205. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

206. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

207. Breast-Cancer Risk in Families With Mutations in PALB2

208. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

210. Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1

211. Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus:Putative Functional Variants Differentially Bind FOXA1 and E2F1

212. Contribution of RAD51D germline mutations in breast and ovarian cancer in Greece

213. Characterization and prevalence of two novel CHEK2large deletions in Greek breast cancer patients

214. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer

215. Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1

216. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

217. Molecular profile and clinical features of patients with gliomas using a broad targeted next generation-sequencing panel.

218. Correction: Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases

219. Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases

220. Abstract 90: An evaluation of the genes involved in the Base Excision Repair (BER) pathway as potential phenotypic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

221. Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer

222. Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6in a Greek cohort of Lynch syndrome suspected families

227. The Role of Phosphoinositide 3-Kinase C2α in Insulin Signaling

228. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

229. Large-scale genotyping identifies 41 new loci associated with breast cancer risk.

230. Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases.

231. Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.

232. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

233. An In-Frame Exon-Skipping MUTYHMutation Is Associated With Early-Onset Colorectal Cancer

234. Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes.

235. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

236. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

237. Additional file 2: of Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

238. Additional file 3: of Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

239. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

240. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

241. The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries

242. Additional file 6: of Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

243. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

244. Additional file 4: of Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

245. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

246. Additional file 5: of Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

247. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

248. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

249. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

250. Additional file 4: of Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

Catalog

Books, media, physical & digital resources